SMNRW Semnur Pharmaceuticals, Inc.

Fundamentals / CIK 0001913577 / USD
Other share classes on CIK 0001913577: SMNR

Semnur Pharmaceuticals, Inc. reported $2.01M in total assets and a net loss of $18.71M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SMNRW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$17.56M$8.78M$0-$150.0MFY 2022 Net Income: -$419K2022FY 2023 Net Income: $633K2023FY 2024 Net Income: -$4.69M2024FY 2025 Net Income: -$160.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $2.55M $1.71M -- --
Total Operating Expenses $160.4M $4.69M -- --
Operating Income -$160.4M -$4.69M -$3.17M --
EBITDA -$160.4M -$4.69M -- --
Interest Income -- $1.58M $3.84M $1.22M
Interest Expense -- $96K $37K --
Income Before Tax $0 $0 -- --
Income Tax Expense $0 $0 -- --
Net Income -$160.4M -$4.69M $633K -$419K
Basic EPS -$0.78 -$0.02 -- --
Diluted EPS -$0.78 -$0.02 -- --
Basic Shares Outstanding 204.8M 200.0M -- --
Diluted Shares Outstanding 204.8M 200.0M -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.44M $1.25M $1.27M $714K $1.14M $502K $187K --
Total Operating Expenses $3.58M $4.22M $4.58M $6.16M $152.6M $999K $665K --
Operating Income -$3.58M -$4.22M -$4.58M -$6.16M -$152.6M -$999K -$665K -$776K
EBITDA -$3.58M -$4.22M -$4.58M -$6.16M -$152.6M -$999K -$665K --
Interest Income -- -- -- -- -- $18K $79K $87K
Interest Expense $56K $123K -- -- $0 $28K $27K $27K
Net Income -$3.63M -$4.35M -$4.58M -$6.16M -$152.6M -$999K -$665K -$167K
Basic EPS -$0.02 -$0.02 -$0.02 -- -$0.76 -$0.01 -$0.01 --
Diluted EPS -$0.02 -$0.02 -$0.02 -- -$0.76 -$0.01 -$0.01 --
Basic Shares Outstanding 224.2M 230.2M 230.2M -- 201.7M 200.0M 200.0M --
Diluted Shares Outstanding 224.2M 230.2M 230.2M -- 201.7M 200.0M 200.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $20K $12K $204K $820K
Cash & Short-Term Investments $20K $12K $204K $820K
Other Current Assets $0 $5.98M -- --
Total Current Assets $596K $6.00M $209K $908K
Property, Plant & Equipment, Net $750K $689K -- --
Total Non-Current Assets $750K $689K $50.48M $85.37M
Total Assets $1.35M $6.68M $50.69M $86.28M
Accounts Payable $5.91M $0 -- --
Total Current Liabilities $10.17M $35K $5.60M $1.29M
Total Non-Current Liabilities $11.93M $49.43M $2.89M $2.89M
Total Liabilities $22.10M $49.47M $8.49M $4.18M
Common Stock $23K $20K -- $51
Retained Earnings -$275.8M -$115.4M -$8.28M -$3.27M
Total Stockholders' Equity -$20.75M -$42.78M -$38.09M -$3.27M
Total Equity -$20.75M -$42.78M -$38.09M -$3.27M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $54K $39K $103K $20K $85K -- $2.7K $12K
Cash & Short-Term Investments $54K $39K $103K $20K $85K -- $2.7K $12K
Other Current Assets -- $51K -- $0 $0 -- -- $5.98M
Total Current Assets $1.26M $1.19M $1.22M $596K $85K $14K $2.7K $6.00M
Property, Plant & Equipment, Net $750K $750K $750K $750K $689K -- -- $689K
Total Non-Current Assets $750K $750K $750K $750K $689K $548K $9.15M $689K
Total Assets $2.01M $1.94M $1.97M $1.35M $774K $562K $9.15M $6.68M
Accounts Payable $7.11M $6.92M $6.42M $5.91M $4.29M -- -- $0
Total Current Liabilities $11.28M $10.67M $10.38M $10.17M $10.03M $8.27M $7.85M $35K
Total Non-Current Liabilities $24.04M $20.94M $16.91M $11.93M $5.33M $2.89M $2.89M $49.43M
Total Liabilities $35.31M $31.62M $27.30M $22.10M $15.37M $11.16M $10.74M $49.47M
Common Stock $23K $23K $23K $23K $23K -- -- $20K
Retained Earnings -$288.4M -$284.7M -$280.4M -$275.8M -$269.6M -$11.14M -$10.74M -$115.4M
Total Stockholders' Equity -$33.31M -$29.67M -$25.33M -$20.75M -$14.59M -$44.45M -$43.45M -$42.78M
Total Equity -$33.31M -$29.67M -$25.33M -$20.75M -$14.59M -$44.45M -$43.45M -$42.78M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$160.4M -$4.69M $633K -$419K
Depreciation & Amortization $0 $0 -- --
Stock-Based Compensation $142.4M $660K -- --
Change in Payables $2.15M $0 -- --
Operating Cash Flow -$5.87M -$4.89M -$633K -$426K
Purchases of Investments -- -- -$825K -$84.15M
Investing Cash Flow -- $43.43M $39.71M -$84.15M
Share Repurchases -- -$43.43M -$40.54M --
Financing Cash Flow $5.88M $4.89M -$39.69M $85.40M
Net Change in Cash $8.0K $0 -$615K $820K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.63M -$4.35M -$4.58M -$6.16M -$152.6M -$999K -$665K -$167K
Depreciation & Amortization $0 $0 $0 $0 $0 $0 $0 --
Stock-Based Compensation $855K $1.29M $1.48M $2.03M $140.2M $119K $92K --
Change in Payables $189K $495K $511K $1.62M $521K $0 $0 --
Operating Cash Flow -$2.22M -$2.14M -$2.67M -$3.60M -$2.13M $268K -$399K -$1.41M
Financing Cash Flow $2.24M $2.07M $2.75M $3.54M $2.16M -$220K $394K $1.41M
Net Change in Cash $15K -$64K $83K -$65K $30K $48K -$5.0K -$1.0K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -11918.0% -70.2% 1.2% -0.5%
Current Ratio 0.06x 171.29x 0.04x 0.70x
Quick Ratio 0.00x 0.34x 0.04x 0.63x
Net Income Growth (YoY) -- -841.5% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -931.5% -8629.7% -8345.7% -11918.0% -19951.6% -556.4% -35.4% -61.1%
Current Ratio 0.11x 0.11x 0.12x 0.06x 0.01x 0.00x 0.00x 171.29x
Quick Ratio 0.00x 0.00x 0.01x 0.00x 0.01x -- 0.00x 0.34x
Net Income Growth (YoY) -- -- -- -- -- -- -- -126.5%
Operating Cash Flow Growth (YoY) -- -897.8% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001913577) · from March 31, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal